Global Custom Market Research Reports Provider Company

phone

Global Stem Cell Therapy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

  • Published Date: 08 Nov 2017
  • Number of Pages: 213
  • Category: Healthcare and Medical
  • Country: Global
Global Stem Cell Therapy Market:

Global stem cell therapy market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for stem cell therapy is projected to reach US$ XX Mn by 2023.

Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every tissue and organ in the body. Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others.

Growing awareness about the potency of stem cells in disease management, development of advanced gene based analysis techniques and increase in public, private investments in stem cell research are acting as growth drivers for stem cell therapy market. In addition, identification of new stem cell lines and development of infrastructure for stem cell banking & processing are propelling the growth of the global stem cell therapy market. However, ethical issues involved in stem cells research such as destruction of human embryos, religious beliefs are considered as road blocks for adaptation of stem cell therapy by patients. However, stringent regulations to conduct trials on humans, high-cost of research and storage of stem cells are some restraining factors for stem cell therapy market.

Stem cell therapy market has been segmented on the basis of treatment mode, cell types, application, technology, and end-user

Based on treatment, stem cell therapy market is segmented into

Allogeneic
Autologous

Based on cell type, stem cell therapy market is segmented into

Adult Stem cells
Induced Pluripotent Stem cells
Human Embryonic Stem Cells
Others

Based on technology, stem cell therapy market is segmented into

Cell Production
Cell Acquisition
Cryopreservation

Based on end-user, stem cell therapy market segmented into

Hospitals
Ambulatory Centers
Research Centers

Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDIs induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership withBe The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.

Geographically stem cell therapy market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among the regions, North America dominates global stem cell therapy market due to factors such as increasing prevalence of chronic diseases, growing awareness, and rising investment in research and development activities. In Asia Pacific region, due to the favourable government policies, development healthcare infrastructure, industry collaborations in research and developments expected to boost stem cell therapy market. For instance, in April 2017, Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR), Singapore, and the Nanyang Technological University (NTU), Singapore, to progress its therapeutic stem cell pipeline.

Some of the players in stem cell therapy market are Cytori Therapeutics Inc. (U.S.), Fibrocell Science (U.S.), Cellartis AB (Cellectis) (France), BioTime, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific(U.S.), STEMCELL Technologies Inc. (Canada), Fujifilm Holdings Corporation (Japan), Vericel Corporation (Aastrom Bioscience) (U.S.), Brainstorm cell therapeutics (U.S.), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), Celgene Corporation (U.S.), and Osiris Therapeutics, Inc. (U.S.) to name a few.

In February 2016, Mesoblast Limiteds licensee in Japan, JCR Pharmaceuticals Co. Ltd., launched TEMCELL HS Inj, the first allogeneic cell therapy to be fully approved in Japan, for the treatment of acute graft versus host disease in children and adults

Report Outline:

The report provides granular level information about the market size, regional market share and forecast from 2017-2023
The report covers in-detail insights about the competitors overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startups details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Publisher Name : Precision Business Insights
1. Executive summary
2. Global Stem Cell Therapy Market Introduction
2.1. Global Stem Cell Therapy Market Taxonomy
2.2. Global Stem Cell Therapy MarketDefinitions
2.2.1. Treatment Type
2.2.2. Cell Type
3. Global Stem Cell Therapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Stem Cell Therapy Market Dynamics Factors Impact Analysis
3.6. Global Stem Cell Therapy Market Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
4. Global Stem Cell Therapy Market Analysis, 2012 - 2016 and Forecast, 2017 2023
4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Stem Cell Therapy Market, By Treatment Type, 2012 - 2016 and Forecast, 2017 - 2023
5.1. Allogeneic
5.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Autologous
5.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Stem Cell Therapy Market Forecast, By Cell Type, 2012 - 2016 and Forecast, 2017 - 2023
6.1. Adult Stem Cells
6.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Induced Pluripotent Stem Cells
6.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Human Embryonic Stem Cells
6.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Stem Cell Therapy Market Forecast, By End User, 2012 - 2016 and Forecast, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Research Centers
7.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Stem Cell Therapy Market Forecast, By Region, 2012 - 2016 and Forecast, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Stem Cell Therapy Market- Opportunity Analysis Index - By Treatment Type, By Cell Type, By End User, and Region, 2017 2023
9. North America Stem Cell Therapy Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.1.1. Treatment Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Allogeneic
9.1.1.2. Autologous
9.1.2. Cell Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Adult Stem Cells
9.1.2.2. Induced Pluripotent Stem Cells
9.1.2.3. Human Embryonic Stem Cells
9.1.2.4. Others
9.1.3. Technology Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Cell Production
9.1.3.2. Cell Acquisition
9.1.3.3. Cryopreservation
9.1.4. End User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. Hospitals
9.1.4.2. Ambulatory Surgical Centers
9.1.4.3. Research Centers
9.1.5. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.5.1. U.S.
9.1.5.2. Canada
9.1.6. North America Stem Cell Therapy Market- Opportunity Analysis Index - By Treatment Type, By Cell Type, By Technology, By End User, and Country, 2017 2023
9.1.7. North America Stem Cell Therapy Market Dynamics Trends
10. Europe Stem Cell Therapy Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Treatment Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Allogeneic
10.1.1.2. Autologous
10.1.2. Cell Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Adult Stem Cells
10.1.2.2. Induced Pluripotent Stem Cells
10.1.2.3. Human Embryonic Stem Cells
10.1.2.4. Others
10.1.3. Technology Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Cell Production
10.1.3.2. Cell Acquisition
10.1.3.3. Cryopreservation
10.1.4. End User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Ambulatory Surgical Centers
10.1.4.3. Research Centers
10.1.5. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. Germany
10.1.5.2. UK
10.1.5.3. France
10.1.5.4. Spain
10.1.5.5. Italy
10.1.5.6. Russia
10.1.5.7. Poland
10.1.5.8. Rest of Europe
10.1.6. Europe Stem Cell Therapy Market- Opportunity Analysis Index - By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2017 2023
10.1.7. Europe Stem Cell Therapy Market Dynamics Trends
11. Asia-Pacific Stem Cell Therapy Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.1.1. Treatment Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Allogeneic
11.1.1.2. Autologous
11.1.2. Cell Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Adult Stem Cells
11.1.2.2. Induced Pluripotent Stem Cells
11.1.2.3. Human Embryonic Stem Cells
11.1.2.4. Others
11.1.3. Technology Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Cell Production
11.1.3.2. Cell Acquisition
11.1.3.3. Cryopreservation
11.1.4. End User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Ambulatory Surgical Centers
11.1.4.3. Research Centers
11.1.5. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.5.1. Japan
11.1.5.2. China
11.1.5.3. India
11.1.5.4. ASEAN
11.1.5.5. Australia & New Zealand
11.1.5.6. Rest of Asia-Pacific
11.1.6. Asia-Pacific Stem Cell Therapy Market- Opportunity Analysis Index - By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2017 2023
11.1.7. Asia-Pacific Stem Cell Therapy Market Dynamics Trends
12. Latin America Stem Cell Therapy Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
12.1.1. Treatment Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Allogeneic
12.1.1.2. Autologous
12.1.2. Cell Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Adult Stem Cells
12.1.2.2. Induced Pluripotent Stem Cells
12.1.2.3. Human Embryonic Stem Cells
12.1.2.4. Others
12.1.3. Technology Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Cell Production
12.1.3.2. Cell Acquisition
12.1.3.3. Cryopreservation
12.1.4. End User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Ambulatory Surgical Centers
12.1.4.3. Research Centers
12.1.5. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.5.1. Brazil
12.1.5.2. Mexico
12.1.5.3. Argentina
12.1.5.4. Venezuela
12.1.5.5. Rest of Latin America
12.1.6. Latin America Stem Cell Therapy Market- Opportunity Analysis Index - By Treatement Type, By Cell Type Type, By Technology, By End User, and Country, 2017 2023
12.1.7. Latin America Stem Cell Therapy Market Dynamics Trends
13. Middle East & Africa Stem Cell Therapy Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
13.1.1. Treatment Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Allogeneic
13.1.1.2. Autologous
13.1.2. Cell Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Adult Stem Cells
13.1.2.2. Induced Pluripotent Stem Cells
13.1.2.3. Human Embryonic Stem Cells
13.1.2.4. Others
13.1.3. Technology Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Cell Production
13.1.3.2. Cell Acquisition
13.1.3.3. Cryopreservation
13.1.4. End User Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Ambulatory Surgical Centers
13.1.4.3. Research Centers
13.1.5. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.5.1. Gulf Cooperation Council (GCC) Countries
13.1.5.2. Israel
13.1.5.3. South Africa
13.1.5.4. Rest of MEA
13.1.6. MEA Stem Cell Therapy Market- Opportunity Analysis Index - By Treatment Type, By Cell Type, By Technology, By End User, and Country, 2017 2023
13.1.7. MEA Stem Cell Therapy Market Dynamics Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Cytori Therapeutics Inc. (U.S.)
14.2.2. Fibrocell Science (U.S.)
14.2.3. Cellartis AB (Cellectis) (France)
14.2.4. BioTime, Inc. (U.S.)
14.2.5. GE Healthcare (U.S.)
14.2.6. Thermo Fisher Scientific (U.S.)
14.2.7. STEMCELL Technologies Inc. (Canada)
14.2.8. Fujifilm Holdings Corporation (Japan)
14.2.9. Vericel Corporation (Aastrom Bioscience) (U.S.)
14.2.10. Brainstorm cell therapeutics (U.S.)
14.2.11. Osiris Therapeutics, Inc. (U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms


This report studies Basalt Fiber in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from

View Report

This report studies Newborn Screening Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,

View Report

This report studies Near Infrared Imaging in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports